Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-20T19:03:10.800Z Has data issue: false hasContentIssue false

1395 – Quality Of Life And Tnf-a Levels In Mexican Patients With Tuberculosis And Major Depressive Disorder

Published online by Cambridge University Press:  15 April 2020

R.E. Pezoa-Jares
Affiliation:
Clinical Services Division, National Institute of Psychiatry ‘Ramon de la Fuente Muñiz’, Mexico City
A.M. Alvarez-Sekely
Affiliation:
Biochemistry Laboratory, National Institute of Respiratory Diseases, Mexico City
A.L. Lopez-Bago
Affiliation:
Biochemistry Laboratory, National Institute of Respiratory Diseases, Mexico City
J.A. Vasquez-Medina
Affiliation:
Clinical Services Division, National Institute of Psychiatry ‘Ramon de la Fuente Muñiz’, Mexico City
C.S. Cruz-Fuentes
Affiliation:
Clinical Research Subdivision, National Institute of Psychiatry ‘Ramon de la Fuente Muñiz’, Mexico City, Mexico
R. Lascurain-Ledesma
Affiliation:
Biochemistry Laboratory, National Institute of Respiratory Diseases, Mexico City

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Tuberculosis (TB) is an infectious disease whose presentation is dependent on host defenses, whereas neuroimmune disregulations are a feature of major depressive disorder (MDD). There are complex interactions between the immune and nervous systems; Tumor Necrosis Factor alpha (TNF-a) has been shown to play a role in the pathophysiology of both TB and MDD. These diseases are prevalent in Mexico, however there is scant research addressing their comorbidity and related immune mechanisms.

Objectives

Evaluate differences in TNF-a levels and quality of life between subjects with TB and/or MDD.

Methods

Thirty-seven subjects (MDD = 10, TB = 9, TB + MDD = 8, controls = 10) were recruited. Instruments used were the SCID-I, Beck Depression Inventory, Hamilton Depression Scale and the World Health Organization Quality of Life survey. A blood sample was obtained from each subject to assess percentage of mononuclear cells positive for TNF-a, using an intracellular cytokines assay.

Results

Highest mean levels of TNF-a were found in the comorbid TB + MDD group (X = 10.46, DE = 14.59) while the control group had the lowest levels (X = 3.26, DE = 4.93). However, when comparing all groups, no statistically significant differences were found. Mean quality of life scores were lower in the MDD (X = 65.6, DE = 5.4) and TB + MDD (X = 66.2, DE = 14.5) groups. When comparing all groups, there were significant differences between TB vs. MDD (p = 0.013), TB vs. TB + MDD (p = 0.004) and MDD vs. control (p = 0.0002) groups.

Conclusions

No significant differences across groups were found regarding TNF-a levels, while subjects with MDD and TB + MDD showed a worse quality of life.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2013
Submit a response

Comments

No Comments have been published for this article.